Eosinophilic esophagitis and inhalant antigens: Pointing out the roles of allergic rhinitis, immunotherapy and biologic treatment

Eosinophilic esophagitis (EoE) and allergic rhinitis (AR) usually represent the latest manifestations of the atopic march, sharing a common type 2 inflammation response. A relevant prevalence of AR in EoE cohorts has been widely confirmed. An increasing literature assessed the involvement of aeroant...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	World Allergy Organization Journal
المؤلفون الرئيسيون:	Erminia Ridolo, MD, PhD, Francesca Nicoletta, MD, Carlo Lombardi, MD, Giovanni Passalacqua, MD, Gianenrico Senna, MD, Giorgio Walter Canonica, MD
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Elsevier 2024-10-01
الموضوعات:	Allergic rhinitis Eosinophilic esophagitis Inhalant antigens Subcutaneous immunotherapy Sublingual immunotherapy
الوصول للمادة أونلاين:	http://www.sciencedirect.com/science/article/pii/S1939455124001005

مواد مشابهة

Alternatives to Subcutaneous Immunotherapy for Allergic Rhinitis
حسب: Tetsuya Terada, وآخرون
منشور في: (2022-02-01)

Efficacy and immunological changes of sublingual immunotherapy in pediatric allergic rhinitis
حسب: Yinhui Zeng, MD, وآخرون
منشور في: (2023-07-01)

Efficacy and safety of sublingual versus subcutaneous immunotherapy in children with allergic rhinitis: a systematic review and meta-analysis
حسب: Jiumei Yang, وآخرون
منشور في: (2023-12-01)

Patient compliance to sublingual immunotherapy for mite-induced allergic rhinitis: A retrospective study
حسب: Wen-Jin Wan, BN, وآخرون
منشور في: (2024-07-01)

Comparison of rush-subcutaneous and sublingual immunotherapy with house dust mite extract for pediatric allergic rhinitis: A prospective cohort study
حسب: Masaaki Hamada, وآخرون
منشور في: (2023-10-01)

Sublingual Immunotherapy Tablets Relieve Symptoms in Adults with Allergic Rhinitis: A Meta-analysis of Randomized Clinical Trials
حسب: Yi Li, وآخرون
منشور في: (2018-01-01)

Sublingual Immunotherapy in Allergic Rhinitis: Efficacy, Safety, Adherence and Guidelines
حسب: Omar Ali Aboshady, وآخرون
منشور في: (2014-12-01)

Modelling the Costs of Sublingual Immunotherapy versus Subcutaneous Immunotherapy Based on Clinical Appointments and Impacts of Patient Travel in Sweden
حسب: Cardell LO, وآخرون
منشور في: (2024-06-01)

Improvement of the therapeutic management of allergic patients in Europe – An expert think tank's position paper on allergen immunotherapy
حسب: Oliver Pfaar, MD, وآخرون
منشور في: (2025-10-01)

Efficacy and safety of house dust mite sublingual immunotherapy tablets in allergic rhinitis: A systematic review and meta-analysis
حسب: Prapasri Kulalert, MD, PhD, وآخرون
منشور في: (2022-09-01)

Efficacy and safety of sublingual immunotherapy using a combination of Dermatophagoides pteronyssinus and Blomia tropicalis extracts in patients with allergic rhinitis: A randomized, double-blind, placebo-controlled trial
حسب: Priscilla Rios Cordeiro Macedo, MD, MSc, وآخرون
منشور في: (2025-02-01)

Immunotherapy and Asthma in Children
حسب: Maria A. Tosca, وآخرون
منشور في: (2018-08-01)

A systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis
حسب: A Meadows, وآخرون
منشور في: (2013-07-01)

Eosinophilic lingual tonsillitis induced by sublingual immunotherapy: A case series
حسب: Carlo Cavaliere, وآخرون
منشور في: (2020-11-01)

Clinical benefits with 300 IR HDM SLIT tablet in Europeans with house dust mite allergic rhinitis: Post hoc analysis of a large phase 3 trial
حسب: Oliver Pfaar, MD, PhD, وآخرون
منشور في: (2024-01-01)

Multiple-Cytokine Profiling: A Novel Method for Early Prediction of the Efficacy of Sublingual Immunotherapy in Allergic Rhinitis Patients
حسب: Zhang Y, وآخرون
منشور في: (2022-01-01)

Allergen immunotherapy in asthma
حسب: Kazuyuki Nakagome, وآخرون
منشور في: (2024-10-01)

The early-phase transcriptome and the clinical efficacy analysis in three modes of subcutaneous immunotherapy for allergic rhinitis
حسب: Jingyu Huang, MS, وآخرون
منشور في: (2023-08-01)

Real-World Adherence and Evidence of Subcutaneous and Sublingual Immunotherapy in Grass and Tree Pollen-Induced Allergic Rhinitis and Asthma
حسب: Vogelberg C, وآخرون
منشور في: (2020-05-01)

Comparison of allergen immunotherapy practice patterns in inhalant allergies in the United States of America and Europe: Similarities and differences 2023
حسب: Oliver Pfaar, MD, وآخرون
منشور في: (2023-05-01)

Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study)Research in context
حسب: Pascal Demoly, وآخرون
منشور في: (2024-06-01)

Effect of mite-specific subcutaneous immunotherapy on patients with allergic rhinitis
حسب: Guoyan Sun, وآخرون
منشور في: (2024-10-01)

The evidence for commercial house dust mite immunotherapy products: A pragmatic systematic review with narrative synthesis
حسب: Timothy West, MBBS, FRACP, وآخرون
منشور في: (2024-08-01)

Evaluation and Comparison of the Efficacy of Subcutaneous and Sublingual Immunotherapy for the Treatment of Allergic Asthma in Children
حسب: Vojko Berce, وآخرون
منشور في: (2024-06-01)

Role of sublingual immunotherapy in management of patients with moderate to severe allergic rhinitis: 1-year randomized controlled study
حسب: Yasser mohamed fawzy Elbeltagy, وآخرون
منشور في: (2025-06-01)

Sublingual immunotherapy tablet for the treatment of house dust mite allergic rhinitis in Canada: an alternative to minimize treatment costs?
حسب: Anne K. Ellis, وآخرون
منشور في: (2019-04-01)

Efficacy and safety of sublingual immunotherapy for allergic rhinitis: A network meta-analysis
حسب: Zao Ji, وآخرون
منشور في: (2023-03-01)

Effect of nasal irrigation on eosinophil and recurrence in allergic rhinitis
حسب: Agung Sulistyanto, وآخرون
منشور في: (2023-06-01)

CHOICE international survey: Clusters of allergen immunotherapy prescription from French and Spanish cohorts
حسب: Pablo Rodriguez del Rio, MD, PhD, وآخرون
منشور في: (2023-06-01)

Blood and local eosinophil levels in chronic rhinitis: Observations during seasonal allergen exposure and non-exposure
حسب: Xu Xu, MSc, وآخرون
منشور في: (2024-07-01)

Oral immunotherapy with enteric-coated capsules for allergic rhinitis caused by house dust mites
حسب: Han-Zhong Zhang, وآخرون
منشور في: (2024-05-01)

Long-term efficacy of HDM-SCIT in pediatric and adult patients with allergic rhinitis
حسب: Lei Ren, وآخرون
منشور في: (2023-03-01)

Minimization of ragweed allergy immunotherapy costs through use of the sublingual immunotherapy tablet in Canadian children with allergic rhinoconjunctivitis
حسب: Anne K. Ellis, وآخرون
منشور في: (2023-01-01)

Impact on quality of life and safety of sublingual and subcutaneous immunotherapy in children with severe house dust mite and pollen-associated allergic rhinoconjunctivitis
حسب: Thomas Proctor, وآخرون
منشور في: (2020-04-01)

Exosomes Derived hsa-miR-4669 as a Novel Biomarker for Early Predicting the Response of Subcutaneous Immunotherapy in Pediatric Allergic Rhinitis
حسب: Jiang S, وآخرون
منشور في: (2022-09-01)

Determinants and Factors of Satisfaction with Sublingual Immunotherapy in Patients with Allergic Rhinitis
حسب: Silviya Novakova
منشور في: (2020-06-01)

Sublingual immunotherapy adherence in patients with allergic rhinitis: Effects of an intervention based on the information-motivation-behavioral skills model
حسب: Qian Wang, وآخرون
منشور في: (2023-12-01)

Identification of Robust Biomarkers for Early Predicting Efficacy of Subcutaneous Immunotherapy in Children With House Dust Mite-Induced Allergic Rhinitis by Multiple Cytokine Profiling
حسب: Shaobing Xie, وآخرون
منشور في: (2022-01-01)

Predictive value of Der p 2-specific IgE for subcutaneous immunotherapy in children with allergic rhinitis
حسب: Jiayan Wang, وآخرون
منشور في: (2024-10-01)

Safety Profile and Issues of Subcutaneous Immunotherapy in the Treatment of Children with Allergic Rhinitis
حسب: Anang Endaryanto, وآخرون
منشور في: (2022-05-01)